BTCY 0.43 Biotricity, Inc.
| Range: | 0.186-2.15 | Vol Avg: | 72118 | Last Div: | 0 | Changes: | 0.05 |
| Beta: | 1.33 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Feb 16 2018 | Empoloyees: | 55 | ||
| CUSIP: | 09074H104 | CIK: | 0001630113 | ISIN: | US09074H2031 | Country: | US |
| CEO: | Dr. Waqaas Al-Siddiq Ph.D. | Website: | https://www.biotricity.com | ||||
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow